SYNPLOGEN
Synplogen is a start-up company that brings together unique DNA synthesis technologies that Kobe University and others have been developing for nearly 10 years. Utilizing state-of-the-art genetic engineering, information science, and robotics, Synplogen have the technology to synthesize high-throughput.
SYNPLOGEN
Industry:
Biometrics Biopharma Biotechnology
Founded:
2017-02-27
Address:
Hamada, Hyogo, Japan
Country:
Japan
Website Url:
http://www.synplogen.com
Total Employee:
1+
Status:
Active
Total Funding:
100 M JPY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager Google Analytics Google Maps SSL By Default
Similar Organizations
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Current Advisors List
Current Employees Featured
Founder
Investors List
i-nest capital
i-nest capital investment in Venture Round - Synplogen
Spiber
Spiber investment in Corporate Round - Synplogen
Official Site Inspections
http://www.synplogen.com
- Host name: 150.60.226.157
- IP address: 150.60.226.157
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Synplogen"
Synplogen Co., Ltd.
Synplogen Co., Ltd. is a synthetic biology startup established in February 2017, originating from Kobe University’s Graduate School of Science, Technology and Innovation. Using our proprietary DNA synthesis technologies OGABâ„¢ and …See details»
Synplogen - Crunchbase Company Profile & Funding
Synplogen is a start-up company that brings together unique DNA synthesis technologies that Kobe University and others have been developing for nearly 10 years. Utilizing state-of-the-art …See details»
Synplogen Company Profile: Overview and Full News Analysis
Synplogen is a synthetic biology venture company established in February 2017 as a spin-off from the Graduate School of Science and Technology Innovation at Kobe University in Hyogo. The …See details»
Synplogen Company Profile 2024: Valuation, Funding & Investors
Synplogen General Information Description. Developer of a genetic engineering platform designed to perform deoxyribonucleic acid synthesis. The company's platform offers long-chain DNA …See details»
Synplogen - Overview, News & Similar companies | ZoomInfo.com
Dec 6, 2023 Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan Synplogen, a synthetic biology …See details»
Merck Signs MoU with Synplogen to Accelerate Development and ...
And Manufacturing Organization) to streamline viral vector ... Synplogen Co., Ltd. is a synthetic biology startup company founded in 2017 and originated from Kobe University. Utilizing its …See details»
FUJIFILM Toyama Chemical and Synplogen Enter Strategic …
Apr 16, 2024 Synplogen, a pioneering synthetic biology startup company from Graduate School of Science, Technology and Innovation, Kobe University, was established in February 2017. ...See details»
Synplogen - VentureRadar
"Synplogen Co., Ltd. is a synthetic biology startup founded in 2017, originating from Kobe University, Japan. Utilizing its proprietary DNA synthesis technologies "OGABâ„¢ method" and …See details»
Synplogen | VentureRadar
"Synplogen Co., Ltd. is a synthetic biology startup specializing in precision DNA synthesis and gene therapy solutions. Utilizing proprietary technologies OGABâ„¢ and Combinatorial-OGAB, …See details»
Synplogen Co., Ltd.
At Synplogen, we provide a variety of services and develop technologies to rapidly bridge the gap between gene therapy product seeds and clinical trials. ... (government body or …See details»
Synplogen Co., Ltd.
Synplogen Co., Ltd. is a synthetic biology startup established in February 2017, originating from Kobe University’s Graduate School of Science, Technology and Innovation. Using our proprietary DNA synthesis technologies OGABâ„¢ and …See details»
Synplogen and Ginkgo Bioworks Announce Plans to Accelerate …
Dec 6, 2023 Synplogen's OGABâ„¢ DNA synthesis services have the ability to synthesize DNA of various lengths up to 100 kbp. OGAB is also capable of complex DNA synthesis, with features …See details»
Synplogen - Funding, Financials, Valuation & Investors - Crunchbase
Synplogen is a synthetic biology firm that provide DNA synthesis and DNA library construction services. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Synplogen Co., Ltd.
A method using three types of plasmid DNA (triple transfection) is currently the mainstream method for the production of adeno-associated virus (AAV) vectors for gene therapy, however, …See details»
Synplogen - Contacts, Employees, Board Members, Advisors
Organization. Synplogen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Contacts. Edit Contacts Section. We're working on …See details»
Merck Signs MoU with Synplogen to Accelerate Development and ...
Dec 13, 2022 Merck’s Millipore® CTDMO Services (Contract Testing, Development and Manufacturing Organization) to streamline viral vector development and production in Japan ...See details»
Synplogen Co., Ltd.
Viral vectors provided by Synplogen may only be used for research and may not be used for clinical or diagnostic applications. If the provided samples are used for anything other than …See details»
Merck Signs MoU with Synplogen to Accelerate Development and ...
Tokyo, Japan, December 8, 2022 – Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Synplogen, a startup spun …See details»
Synplogen Co., Ltd.
Our OGABâ„¢ method is the only technology in the world that uses Bacillus subtilis for DNA synthesis. By using OGABâ„¢, we can synthesize DNA for difficult sequences with …See details»
Synplogen Co., Ltd.
Mar 7, 2024 Synplogen provides a variety of services including DNA synthesis, DNA library development and synthesis and viral vector development for gene therapy applications.See details»